PCA 31.1
PCA 31.1
规格:
货期:
编号:TS211120
品牌:Testobio
| 产品名称： | PCA 31.1 |
|---|---|
| 商品货号： | TS211120 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | carcinoma |
| Strain： | BALB/c (B cell); BALB/c (myeloma) |
| Applications： | The antibody reacts with human carcinoma associated antigens (CCAA) when assayed by ELISA. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified human carcinoma associated antigens (CCAA) obtained from pooled colon carcinoma membranes. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human carcinoma associated antigens (CCAA) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human carcinoma associated antigens (CCAA) |
| Comments： | Animals were immunized with purified human carcinoma associated antigens (CCAA) obtained from pooled colon carcinoma membranes. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts with human carcinoma associated antigens (CCAA) when assayed by ELISA. |
| Complete Growth Medium： | RPMI 1640 medium without calcium and magnesium, 90%; fetal bovine serum, 10%
|
| Cryopreservation： | fetal bovine serum, 90%; DMSO, 10% |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgG1; kappa light chain |
| Name of Depositor： | International Bioimmune Systems |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Tsang KY, Arlen M. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor. US Patent 5,688,657 dated Nov 18 1997 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
PCA 31.1
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | PCA 31.1 |
|---|---|
| 商品货号： | TS211120 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | carcinoma |
| Strain： | BALB/c (B cell); BALB/c (myeloma) |
| Applications： | The antibody reacts with human carcinoma associated antigens (CCAA) when assayed by ELISA. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified human carcinoma associated antigens (CCAA) obtained from pooled colon carcinoma membranes. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human carcinoma associated antigens (CCAA) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human carcinoma associated antigens (CCAA) |
| Comments： | Animals were immunized with purified human carcinoma associated antigens (CCAA) obtained from pooled colon carcinoma membranes. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts with human carcinoma associated antigens (CCAA) when assayed by ELISA. |
| Complete Growth Medium： | RPMI 1640 medium without calcium and magnesium, 90%; fetal bovine serum, 10%
|
| Cryopreservation： | fetal bovine serum, 90%; DMSO, 10% |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgG1; kappa light chain |
| Name of Depositor： | International Bioimmune Systems |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Tsang KY, Arlen M. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor. US Patent 5,688,657 dated Nov 18 1997 |
